S-1: Bowhead Specialty Holdings Files for IPO, Aiming to List on NYSE

Bowhead Specialty Holdings Inc. has filed for an initial public offering, seeking to list its common stock on the New York Stock Exchange under the ticker symbol 'BOW'.

Summary

• Bowhead Specialty Holdings Inc. has filed a registration statement for an IPO of its common stock.
• The company intends to list its common stock on the NYSE under the symbol 'BOW'.
• Bowhead is an emerging growth company and will take advantage of reduced reporting requirements.
• The company's gross written premiums were $507.7 million for the year ended December 31, 2023, a 42.2% increase from the previous year.
• For the year ended December 31, 2023, Bowhead reported a combined ratio of 95.0%, net income of $25.0 million, and a return on equity of 18.2%.
• The company offers specialty P&C products, focusing on Casualty, Professional Liability, and Healthcare risks.
• Bowhead distributes its products through wholesale and retail channels, with a focus on building strong relationships with leading distributors.
• The company reinsures 100% of its insurance business to its wholly-owned subsidiary, BICI.
• Following the IPO, BIHL will be liquidated, and shares will be distributed to Pre-IPO Investors.
• The company intends to use at least $ million of the net proceeds to us from this offering to make capital contributions to our insurance company subsidiary in order to grow our business and the remainder for general corporate purposes.

Sentiment

Score: 8

Explanation: The document presents a positive outlook for Bowhead, highlighting its growth, profitability, and strategic initiatives. While acknowledging risks, the overall tone is optimistic and confident in the company's future prospects.

Positives

• The company has experienced significant growth in gross written premiums.
• Bowhead has achieved a strong combined ratio and return on equity.
• The company has a strategic partnership with AmFam.
• Bowhead has a nimble and efficient platform with a hybrid operating model and modern technology.
• The company has an experienced and entrepreneurial leadership team.

Negatives

• The company relies on its strategic relationship with AmFam.
• The company faces intense competition in the insurance industry.
• The company's losses and loss expense reserves may be inadequate to cover actual losses.
• The company is subject to extensive regulation, which may adversely affect its ability to achieve its business objectives.
• The company's costs will increase significantly as a result of operating as a public company.

Risks

• Inability to accurately assess underwriting risk could adversely affect financial results.
• Intense competition in the insurance industry could impact pricing and terms.
• Failure to maintain the strategic relationship with AmFam would materially affect the business.
• A decline in AmFam's financial strength rating could adversely affect the company's operations.
• Reliance on insurance retail agents, brokers, and wholesalers exposes the company to certain risks.
• Inability to purchase third-party reinsurance on acceptable terms could increase loss exposure.
• Inadequate loss and loss expense reserves could materially affect financial condition.
• Reliance on third-party data, and inaccuracies in such data, could adversely impact the ability to estimate losses and manage risks.
• Unexpected changes in the interpretation of coverage or provisions in policies could have a material adverse effect.
• Reinsurers may not reimburse claims on a timely basis, or at all.
• Adverse economic factors could result in fewer policies sold or an increase in the frequency of claims.
• Performance of the investment portfolio is subject to a variety of investment risks.
• Extensive regulation may adversely affect the ability to achieve business objectives.
• Loss of key personnel or inability to attract and retain qualified personnel could be detrimental.
• Security breaches, loss of data, cyberattacks, and other information technology failures could disrupt operations.
• Costs will increase significantly as a result of operating as a public company.
• The company will be a controlled company within the meaning of the rules of NYSE.

Future Outlook

The company believes its current market opportunity, expertise, relationships, culture, and leadership team position it well to continue growing its business profitably and intends to launch an E&S initiative focused on small, niche, hard-to-place risks in the second quarter of 2024.

Management Comments

• 'Everything we do is focused on building a best-in-class organization to last forever,' said Stephen Sills, Founder and CEO.

Industry Context

The company operates in the specialty P&C market, which has seen significant pricing dislocations and growth in the E&S market. The U.S. commercial E&S market generated approximately $83.3 billion in direct premiums written in 2023, representing approximately 17.9% of the overall U.S. commercial P&C market.

Comparison to Industry Standards

• The document mentions that Bowhead's target markets have outperformed the broader U.S. commercial E&S market in loss ratio by four points annually on average over the same five-year period.
• The document references A.M. Best's financial strength rating for AmFam as A (Excellent), which is a standard benchmark for assessing insurance company financial stability.
• The document references the S&P 500's annualized returns during the periods when Stephen Sills led Darwin Professional Underwriters Inc. and Executive Risk Inc., providing a benchmark for his past performance.

Related Party Transactions

• BICI has a Quota Share Agreement with AFMIC, where BICI assumes 100.0% of certain risks and AmFam receives a ceding fee.
• BSUI has MGA Agreements with AmFam Issuing Carriers, where BSUI issues policies and provides services for a commission.
• In 2023 and 2022, BICI entered into a ceded Quota Share Reinsurance Agreement and a ceded Excess of Loss Reinsurance Agreement with reinsurers, in which a separate subsidiary of AmFam participated.
• Under the BIHL LPA, at any time until December 31, 2024 AFMIC has an option to purchase from each of the other general and limited partners and their respective assignees all such partners interests and assignees rights subject to certain conditions as set forth in the BIHL LPA (the AFMIC Purchase Option). In connection with this offering, AFMIC has agreed to waive the AFMIC Purchase Option in full.

Stakeholder Impact

• The IPO will increase the company's capitalization and financial flexibility, benefiting shareholders.
• The company's growth and profitability will create opportunities for employees.
• The company's focus on providing craft solutions and excellent service will benefit policyholders and distribution partners.

Next Steps

• The company intends to list its common stock on the NYSE under the symbol 'BOW'.
• The company plans to launch Baleen Specialty, an E&S initiative focused on small, niche risks, in the second quarter of 2024.
• Following the IPO, BIHL will be liquidated, and shares will be distributed to Pre-IPO Investors.

Key Dates

Keywords

IPO, initial public offering, insurance, specialty P&C, Bowhead Specialty Holdings, reinsurance, underwriting, financials, NYSE, BIHL, AmFam, GPC Fund